Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Banminth
2. Tartrate, Pyrantel
1. 33401-94-4
2. Pyrantel Tartrate Salt
3. Banminth
4. Pyrantel Tartrate [usan]
5. Pyrantel (tartrate)
6. Pyrantel (+)-tartrate Salt
7. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
8. Sc82vf0480
9. (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine Tartrate (1:1)
10. Pyrequan Tartrate
11. Cp-10,423-18
12. Dsstox_cid_28784
13. Dsstox_rid_83053
14. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-, (e)-, Tartrate (1:1)
15. Dsstox_gsid_48858
16. (2r,3r)-2,3-dihydroxybutanedioic Acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
17. Pyrantel Bitartrate
18. Pyrantel Hydrogen Tartrate
19. Banminth 48
20. Einecs 251-501-8
21. Unii-sc82vf0480
22. Cp 10423-18
23. (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine Tartrate (1:1)
24. Ncgc00017103-02
25. Banminth (tn)
26. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]-, (e)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
27. Cas-33401-94-4
28. Pyranteltartrate
29. Prestwick3_000212
30. Pyrantel Tartrate (usp)
31. Bspbio_000223
32. Schembl536109
33. Pyrantel Tartrate [mi]
34. Bpbio1_000247
35. Chembl2105309
36. Dtxsid4048858
37. Hms2095l05
38. Hms3712l05
39. Pyrantel Tartrate [usp-rs]
40. Tox21_113347
41. Akos016014952
42. Pyrantel Tartrate [green Book]
43. Tox21_113347_1
44. Ccg-220212
45. Cs-3870
46. Ncgc00174007-04
47. Pyrantel Tartrate [usp Monograph]
48. Hy-12641
49. 2(1h)-pyrimidinone, 4,6-diamino-5-nitroso-
50. D05657
51. A875297
52. Sr-01000872648
53. Sr-01000872648-1
54. Q27289138
55. Pyrantel Tartrate, United States Pharmacopeia (usp) Reference Standard
56. Trans-1-methyl-1,4,5,6-tetrahydro-2-(2-(thienyl)vinyl)pyrimidine Tartrate
57. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine (2r,3r)-2,3-dihydroxysuccinate
Molecular Weight | 356.4 g/mol |
---|---|
Molecular Formula | C15H20N2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 356.10420754 g/mol |
Monoisotopic Mass | 356.10420754 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 382 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anthelmintics
Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?